⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2001020 | 0.70 | — | — | |
| SCHEMBL13662353 | 0.60 | GAA (0.30) | — | |
| SCHEMBL15243777 | 0.60 | — | — | |
| SCHEMBL2437875 | 0.56 | — | — | |
| SCHEMBL3939892 | 0.56 | — | — | |
| SCHEMBL7252760 | 0.56 | — | — | |
| SCHEMBL30480058 | 0.56 | — | — | |
| SCHEMBL1664168 | 0.56 | — | — | |
| SCHEMBL3933600 | 0.55 | — | — | |
| SCHEMBL3930826 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6667306-B1 | Aminobenzothiazole and aminobenzoxazole derivatives; thrombosis | MILLENNIUM PHARMACEUTICALS, INC. | 2003-12-23 | — | — | US | disclosed |
| EP-1047699-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 2000-11-02 | — | — | EP | disclosed |
| WO-1999036425-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 1999-07-22 | — | — | WO | disclosed |